Comparison of Clinical Profiles, Demographics, and Surgical Outcomes of 25-Gauge Vitrectomy for Proliferative Diabetic Retinopathy in Young Adults with Type 1 or Type 2 Diabetes
暂无分享,去创建一个
Gezhi Xu | Xin Huang | Juan Zhang | Lu Ruan | Meng Zhang
[1] Ting Zhang,et al. Clinical Characteristics and Surgical Outcomes of Complications of Proliferative Diabetic Retinopathy in Young versus Older Patients with Type 2 Diabetes , 2023, Diabetes, metabolic syndrome and obesity : targets and therapy.
[2] Jiyang Tang,et al. Prospective Comparison of Surgery Outcome Between Preoperative and Intraoperative Intravitreal Injection of Ranibizumab for Vitrectomy in Proliferative Diabetic Retinopathy Patients , 2022, Ophthalmology and Therapy.
[3] Wei Wang,et al. Association of different kinds of obesity with diabetic retinopathy in patients with type 2 diabetes , 2022, BMJ Open.
[4] D. Hodge,et al. Ocular Sequelae in a Population-Based Cohort of Youth Diagnosed With Diabetes During a 50-Year Period. , 2021, JAMA ophthalmology.
[5] R. Channa,et al. Pediatric Diabetic Retinopathy: Updates in Prevalence, Risk Factors, Screening, and Management , 2021, Current Diabetes Reports.
[6] K. Ramasamy,et al. Clinical features and surgical outcomes of complications of proliferative diabetic retinopathy in young adults with type 1 diabetes mellitus versus type 2 diabetes mellitus - A comparative observational study , 2021, Indian journal of ophthalmology.
[7] A. Galli-Tsinopoulou,et al. Diagnosis, treatment and prevention of type 2 diabetes mellitus in children and adolescents , 2021, World journal of diabetes.
[8] W. Wong,et al. Incidence and clinical characteristics of pediatric‐onset type 2 diabetes in Hong Kong: The Hong Kong childhood diabetes registry 2008 to 2017 , 2021, Pediatric diabetes.
[9] C. Wykoff,et al. Risk of Blindness Among Patients With Diabetes and Newly Diagnosed Diabetic Retinopathy , 2021, Diabetes Care.
[10] H. Yamashita,et al. Factors correlated with visual outcomes at two and four years after vitreous surgery for proliferative diabetic retinopathy , 2021, PloS one.
[11] Rui Zeng,et al. The incidence and risk factors of neovascular glaucoma secondary to proliferative diabetic retinopathy after vitrectomy , 2020, European journal of ophthalmology.
[12] Wei Zhang,et al. Trends and geographic variations in self‐reported diabetes incidence: A prospective open cohort study of Chinese men and women, 1997–2015 , 2020, Diabetic medicine : a journal of the British Diabetic Association.
[13] Bo Huang,et al. Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients , 2020, BMC Ophthalmology.
[14] C. Marcus,et al. Microalbuminuria and retinopathy in adolescents and young adults with type 1 and type 2 diabetes , 2020, Pediatric diabetes.
[15] T. Y. A. Liu,et al. Prevalence of diabetic retinopathy in children and adolescents at an urban tertiary eye care center , 2020, Pediatric diabetes.
[16] R. Kowluru. Retinopathy in a Diet-Induced Type 2 Diabetic Rat Model and Role of Epigenetic Modifications , 2020, Diabetes.
[17] Zhi-zhong Ma,et al. Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy. , 2020, Annals of Palliative Medicine.
[18] Till Bärnighausen,et al. Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030 , 2018, Diabetes Care.
[19] 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018 , 2017, Diabetes Care.
[20] Chung-May Yang,et al. Vitrectomy for complications of proliferative diabetic retinopathy in young adults: clinical features and surgical outcomes , 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.
[21] R. D. Gross,et al. Screening for Retinopathy in the Pediatric Patient With Type 1 Diabetes Mellitus , 2016, Pediatric Clinical Practice Guidelines & Policies.
[22] D. Maberley,et al. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR PROLIFERATIVE DIABETIC RETINOPATHY: A Systematic Review and Meta-Analysis , 2015, Retina.
[23] D. Witherspoon,et al. Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study , 2015, Diabetology & Metabolic Syndrome.
[24] Jasmin Divers,et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. , 2014, JAMA.
[25] H. Mugishima,et al. Screening and treatment of childhood type 1 and type 2 diabetes mellitus in Japan. , 2012, Pediatric endocrinology reviews : PER.
[26] D. Yorston,et al. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy , 2008, British Journal of Ophthalmology.
[27] Chung-May Yang,et al. Extended Silicone Oil Tamponade in Primary Vitrectomy for Complex Retinal Detachment in Proliferative Diabetic Retinopathy: A Long-Term Follow-Up Study , 2007, European journal of ophthalmology.
[28] L. Chuang,et al. National surveillance for type 2 diabetes mellitus in Taiwanese children. , 2003, JAMA.
[29] M. Blumenkranz,et al. Silicone oil for the treatment of severe proliferative diabetic retinopathy. , 1989, Ophthalmology.
[30] Junfen Fu,et al. Changing Epidemiology of Metabolic Syndrome and Type 2 Diabetes in Chinese Youth , 2013, Current Diabetes Reports.
[31] D. Power. Standards of medical care in diabetes. , 2006, Diabetes care.